| Utestående aktier | 11,610,371 shares |
| Insideraktier | 3 533 884 shares |
| Insynsägande | 30,44 % |
| Totalt antal insynspersoner | 28 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
61 out of 10786
Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Surrozen, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
Mitchell J Md Blutt
10% Owner -
|
0 | 0 | |
| Anna Berkenblit Director - [D] | 35 129 | 2 342 | |
| Christopher Y Chai Director - [D] | 35 129 | 2 342 | |
|
Column Group Iii Gp, Lp
10% Owner -
|
1 361 485 | 1 361 485 | |
|
Column Group Iii, Lp
10% Owner -
|
4 904 884 | 1 361 485 | |
|
Column Group Iii-a, Lp
10% Owner -
|
4 904 884 | 1 361 485 | |
|
Consonance Capital Management LP
Director, 10% Owner -
[D]
|
450 828 | 0 | |
| Consonance Capital Opportunity Fund Management LP Director - [D] | 0 | 128 900 | |
| Consonance Capman GP, LLC Director - [D] | 450 828 | 0 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
Consonance Life Sciences
10% Owner -
|
1 885 000 | 0 | |
| Mary Haak-Frendscho Director - [D] | 35 129 | 2 342 | |
| Christopher Haqq - | 30 000 | 2 000 | |
| Joshua Cory House | 0 | ||
| Jennifer Jarrett - | 30 000 | 2 000 | |
|
Tim Kutzkey
Director, 10% Owner -
[D]
|
1 361 485 | 1 361 485 | |
| Yang Li Exec. Vice President, Research - [O] | 17 216 | 17 216 | |
| Shao-Lee Lin Director - [D] | 35 129 | 2 342 | |
|
Kevin Harold Livingston
10% Owner -
|
1 885 000 | 0 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Craig C Parker Chief Executive Officer, Director - [D] [O] | 16 553 | 16 553 | |
| Mace Rothenberg Director - [D] | 35 129 | 2 342 | |
| Donald J Santel - | 30 000 | 2 000 | |
|
Benny Soffer
10% Owner -
|
1 885 000 | 0 | |
| Gad Soffer | 0 | ||
|
TCG Crossover GP II, LLC
10% Owner -
|
736 547 | 736 547 | |
| Geertrui Vanhove Chief Medical Officer - [O] | 32 412 | 2 161 | |
| David J Woodhouse Director - [D] | 35 129 | 2 342 | |
| Charles O Williams Chief Operating Officer - [O] | 16 571 | 16 571 | |
| Wen-Chen Yeh Chief Scientific Officer - [O] | 27 216 | 1 814 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i SRZN / Surrozen, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i SRZN / Surrozen, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-05 | 2026-05-04 | 4 | Li Yang | SRZN | Common Stock | D | 33,3328 | −1 584 | −53 | 17 216 | ||||
| 2026-05-05 | 2026-05-01 | 4 | Li Yang | SRZN | Common Stock | D | 4 375 | 18 800 | ||||||
| 2026-05-05 | 2026-05-04 | 4 | Williams Charles O | SRZN | Common Stock | D | 33,3328 | −2 036 | −68 | 16 571 | ||||
| 2026-05-05 | 2026-05-01 | 4 | Williams Charles O | SRZN | Common Stock | D | 5 625 | 18 607 | ||||||
| 2026-05-05 | 2026-05-04 | 4 | Parker Craig C | SRZN | Common Stock | D | 33,3328 | −4 524 | −151 | 16 553 | ||||
| 2026-05-05 | 2026-05-01 | 4 | Parker Craig C | SRZN | Common Stock | D | 12 500 | 21 077 | ||||||
| 2026-04-01 | 2026-03-31 | 4 | Li Yang | SRZN | Common Stock | D | −1 666 | 14 425 | ||||||
| 2026-03-25 | 2026-03-24 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,6931 | 53 329 | 1 317 | 736 547 | ||||
| 2026-03-25 | 2026-03-24 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,6931 | 53 329 | 1 317 | 736 554 | ||||
| 2026-03-25 | 2026-03-23 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,8999 | 7 611 | 190 | 683 218 | ||||
| 2026-03-25 | 2026-03-23 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,8999 | 7 612 | 190 | 683 225 | ||||
| 2026-03-16 | 2026-03-16 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,9857 | 595 | 15 | 675 610 | ||||
| 2026-03-16 | 2026-03-16 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,9857 | 595 | 15 | 675 613 | ||||
| 2026-03-16 | 2026-03-13 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,8769 | 17 716 | 441 | 675 015 | ||||
| 2026-03-16 | 2026-03-13 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,8769 | 17 717 | 441 | 675 018 | ||||
| 2026-03-16 | 2026-03-12 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,9851 | 6 187 | 155 | 657 299 | ||||
| 2026-03-16 | 2026-03-12 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 24,9851 | 6 187 | 155 | 657 301 | ||||
| 2026-02-13 | 2026-02-12 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 23,8625 | 546 | 13 | 651 112 | ||||
| 2026-02-13 | 2026-02-12 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 23,8625 | 547 | 13 | 651 114 | ||||
| 2026-02-13 | 2026-02-11 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 23,5750 | 8 881 | 209 | 650 563 | ||||
| 2026-02-13 | 2026-02-11 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 23,5750 | 8 882 | 209 | 650 567 | ||||
| 2026-02-03 | 2026-02-03 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 21,9400 | 2 177 | 48 | 641 682 | ||||
| 2026-02-03 | 2026-02-03 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 21,9400 | 2 178 | 48 | 641 685 | ||||
| 2026-02-03 | 2026-02-02 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 21,3800 | 365 | 8 | 639 505 | ||||
| 2026-02-03 | 2026-02-02 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 21,3800 | 366 | 8 | 639 507 | ||||
| 2026-02-03 | 2026-01-30 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 21,3900 | 2 135 | 46 | 639 140 | ||||
| 2026-02-03 | 2026-01-30 | 4 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 21,3900 | 2 136 | 46 | 639 141 | ||||
| 2026-01-28 | 3 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 637 005 | ||||||||
| 2026-01-28 | 3 | TCG Crossover GP II, LLC | SRZN | Common Stock | I | 637 005 | ||||||||
| 2026-01-20 | 2026-01-20 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 19,5999 | 9 568 | 188 | 1 016 658 | ||||
| 2026-01-20 | 2026-01-20 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 19,5999 | 8 484 | 166 | 900 292 | ||||
| 2026-01-20 | 2026-01-16 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 20,0000 | 1 358 | 27 | 1 007 090 | ||||
| 2026-01-20 | 2026-01-16 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 20,0000 | 1 204 | 24 | 891 808 | ||||
| 2026-01-20 | 2026-01-15 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 19,8890 | 6 303 | 125 | 1 005 732 | ||||
| 2026-01-20 | 2026-01-15 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 19,8890 | 5 590 | 111 | 890 604 | ||||
| 2026-01-20 | 2026-01-20 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 19,5999 | 9 568 | 188 | 1 016 658 | ||||
| 2026-01-20 | 2026-01-20 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 19,5999 | 8 484 | 166 | 900 292 | ||||
| 2026-01-20 | 2026-01-16 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 20,0000 | 1 358 | 27 | 1 007 090 | ||||
| 2026-01-20 | 2026-01-16 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 20,0000 | 1 204 | 24 | 891 808 | ||||
| 2026-01-20 | 2026-01-15 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 19,8890 | 6 303 | 125 | 1 005 732 | ||||
| 2026-01-20 | 2026-01-15 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 19,8890 | 5 590 | 111 | 890 604 | ||||
| 2026-01-15 | 2026-01-14 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 19,9883 | 2 927 | 59 | 999 429 | ||||
| 2026-01-15 | 2026-01-14 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 19,9883 | 2 596 | 52 | 885 014 | ||||
| 2026-01-15 | 2026-01-13 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 19,8041 | 6 609 | 131 | 996 502 | ||||
| 2026-01-15 | 2026-01-13 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 19,8041 | 5 861 | 116 | 882 418 | ||||
| 2026-01-15 | 2026-01-14 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 19,9883 | 2 927 | 59 | 999 429 | ||||
| 2026-01-15 | 2026-01-14 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 19,9883 | 2 596 | 52 | 885 014 | ||||
| 2026-01-15 | 2026-01-13 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 19,8041 | 6 609 | 131 | 996 502 | ||||
| 2026-01-15 | 2026-01-13 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 19,8041 | 5 861 | 116 | 882 418 | ||||
| 2026-01-08 | 2026-01-06 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 19,8872 | 8 003 | 159 | 989 893 | ||||
| 2026-01-08 | 2026-01-06 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 19,8872 | 7 097 | 141 | 876 557 | ||||
| 2026-01-08 | 2026-01-06 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 19,8872 | 8 003 | 159 | 989 893 | ||||
| 2026-01-08 | 2026-01-06 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 19,8872 | 7 097 | 141 | 876 557 | ||||
| 2026-01-06 | 2026-01-05 | 4 | Li Yang | SRZN | Common Stock | D | 19,8652 | −1 118 | −22 | 16 091 | ||||
| 2026-01-06 | 2026-01-02 | 4 | Li Yang | SRZN | Common Stock | D | 2 500 | 17 209 | ||||||
| 2026-01-06 | 2026-01-05 | 4 | Williams Charles O | SRZN | Common Stock | D | 19,8652 | −1 566 | −31 | 12 982 | ||||
| 2026-01-06 | 2026-01-02 | 4 | Williams Charles O | SRZN | Common Stock | D | 3 500 | 14 548 | ||||||
| 2025-12-16 | 2025-12-15 | 4 | Li Yang | SRZN | Common Stock | D | 8,1100 | 1 666 | 14 | 14 709 | ||||
| 2025-12-16 | 2025-12-15 | 4 | Williams Charles O | SRZN | Common Stock | D | 8,1100 | 1 666 | 14 | 11 048 | ||||
| 2025-12-16 | 2025-12-15 | 4 | Parker Craig C | SRZN | Common Stock | D | 8,1100 | 1 553 | 13 | 8 577 | ||||
| 2025-12-08 | 2025-12-05 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 19,5409 | 16 381 | 320 | 981 890 | ||||
| 2025-12-08 | 2025-12-05 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 19,5409 | 14 503 | 283 | 869 460 | ||||
| 2025-12-08 | 2025-12-04 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 17,3470 | 2 791 | 48 | 965 509 | ||||
| 2025-12-08 | 2025-12-04 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 17,3470 | 2 475 | 43 | 854 957 | ||||
| 2025-12-08 | 2025-12-05 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 19,5409 | 16 381 | 320 | 981 890 | ||||
| 2025-12-08 | 2025-12-05 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 19,5409 | 14 503 | 283 | 869 460 | ||||
| 2025-12-08 | 2025-12-04 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 17,3470 | 2 791 | 48 | 965 509 | ||||
| 2025-12-08 | 2025-12-04 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 17,3470 | 2 475 | 43 | 854 957 | ||||
| 2025-12-02 | 2025-11-13 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 12,6500 | 167 307 | 2 116 | 962 718 | ||||
| 2025-12-02 | 2025-11-13 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 12,6500 | 148 150 | 1 874 | 852 482 | ||||
| 2025-11-17 | 2025-11-13 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 12,6500 | 167 307 | 2 116 | 962 718 | ||||
| 2025-11-17 | 2025-11-13 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 12,6500 | 148 150 | 1 874 | 852 482 | ||||
| 2025-06-16 | 2025-06-13 | 4 | Li Yang | SRZN | Common Stock | D | 8,0600 | 400 | 3 | 13 043 | ||||
| 2025-06-16 | 2025-06-13 | 4 | Williams Charles O | SRZN | Common Stock | D | 8,0600 | 400 | 3 | 9 382 | ||||
| 2025-06-16 | 2025-06-13 | 4 | Parker Craig C | SRZN | Common Stock | D | 8,0600 | 400 | 3 | 7 024 | ||||
| 2025-03-28 | 3 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 795 411 | ||||||||
| 2025-03-28 | 3 | Kutzkey Tim By The Column Group Opportunity III, LP | SRZN | Common Stock | I | 344 827 | ||||||||
| 2025-03-28 | 3 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 704 332 | ||||||||
| 2025-03-28 | 2025-03-26 | 4 | COLUMN GROUP III GP, LP By The Column Group Opportunity III, LP | SRZN | Common Stock | I | 11,6000 | 344 827 | 4 000 | 344 827 | ||||
| 2025-03-28 | 2025-03-26 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 11,6000 | 365 769 | 4 243 | 795 411 | ||||
| 2025-03-28 | 2025-03-26 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 11,6000 | 323 886 | 3 757 | 704 332 | ||||
| 2025-01-06 | 2025-01-03 | 4 | Li Yang | SRZN | Common Stock | D | 17,3700 | −843 | −15 | 13 345 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Li Yang | SRZN | Common Stock | D | 2 500 | 14 188 | ||||||
| 2025-01-06 | 2025-01-03 | 4 | Williams Charles O | SRZN | Common Stock | D | 17,3700 | −1 181 | −21 | 8 982 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Williams Charles O | SRZN | Common Stock | D | 3 500 | 10 163 | ||||||
| 2024-06-18 | 2024-06-14 | 4 | Li Yang | SRZN | Common Stock | D | 5,6700 | 400 | 2 | 10 888 | ||||
| 2024-06-18 | 2024-06-14 | 4 | Williams Charles O | SRZN | Common Stock | D | 5,6700 | 400 | 2 | 5 863 | ||||
| 2024-06-18 | 2024-06-14 | 4 | Parker Craig C | SRZN | Common Stock | D | 5,6700 | 400 | 2 | 5 824 | ||||
| 2024-04-17 | 2024-04-04 | 4/A | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 15,5000 | 102 651 | 1 591 | 326 992 | ||||
| 2024-04-17 | 2024-04-04 | 4/A | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 15,5000 | 90 897 | 1 409 | 289 549 | ||||
| 2024-04-17 | 2024-04-04 | 4/A | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 15,5000 | 102 651 | 1 591 | 326 992 | ||||
| 2024-04-17 | 2024-04-04 | 4/A | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 15,5000 | 90 897 | 1 409 | 289 549 | ||||
| 2024-04-08 | 2024-04-04 | 4 | Williams Charles O | SRZN | Common Stock | D | 1 474 | 1 474 | ||||||
| 2024-04-08 | 2024-04-04 | 4 | Parker Craig C | SRZN | Common Stock | D | 1 474 | 1 474 | ||||||
| 2024-04-08 | 2024-04-04 | 4 | COLUMN GROUP III GP, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 15,5000 | 102 651 | 1 591 | 332 885 | ||||
| 2024-04-08 | 2024-04-04 | 4 | COLUMN GROUP III GP, LP By The Column Group III, LP | SRZN | Common Stock | I | 15,5000 | 90 897 | 1 409 | 294 767 | ||||
| 2024-04-08 | 2024-04-04 | 4 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 15,5000 | 102 651 | 1 591 | 332 885 | ||||
| 2024-04-08 | 2024-04-04 | 4 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 15,5000 | 90 897 | 1 409 | 294 767 | ||||
| 2023-12-18 | 2023-12-15 | 4 | Williams Charles O | SRZN | Common Stock | D | 5,6700 | 2 085 | 12 | 2 085 | ||||
| 2023-12-18 | 2023-12-15 | 4 | Li Yang | SRZN | Common Stock | D | 5,6700 | 2 085 | 12 | 2 085 | ||||
| 2023-12-18 | 2023-12-15 | 4 | Parker Craig C | SRZN | Common Stock | D | 5,6700 | 2 046 | 12 | 2 046 | ||||
| 2023-08-23 | 3 | Li Yang | SRZN | Common Stock | I | 10 538 | ||||||||
| 2023-08-23 | 3 | Li Yang | SRZN | Common Stock | D | 121 524 | ||||||||
| 2023-06-20 | 2023-06-15 | 4 | Yeh Wen-Chen | SRZN | Common Stock | D | 0,3800 | 17 638 | 7 | 27 216 | ||||
| 2023-06-20 | 2023-06-15 | 4 | Parker Craig C | SRZN | Common Stock | D | 0,3800 | 25 000 | 10 | 34 578 | ||||
| 2023-06-20 | 2023-06-15 | 4 | Williams Charles O | SRZN | Common Stock | D | 0,3800 | 25 000 | 10 | 34 578 | ||||
| 2022-12-19 | 2022-12-15 | 4 | Yeh Wen-Chen | SRZN | Common Stock | D | 0,4100 | 9 578 | 4 | 229 138 | ||||
| 2022-12-19 | 2022-12-15 | 4 | Parker Craig C | SRZN | Common Stock | D | 0,4100 | 9 578 | 4 | 9 578 | ||||
| 2022-12-19 | 2022-12-15 | 4 | Vanhove Geertrui | SRZN | Common Stock | D | 0,4100 | 9 578 | 4 | 32 412 | ||||
| 2022-12-19 | 2022-12-15 | 4 | Williams Charles O | SRZN | Common Stock | D | 0,4100 | 9 578 | 4 | 9 578 | ||||
| 2022-12-15 | 2022-12-14 | 4 | BLUTT MITCHELL J MD By Consonance Life Sciences, LLC | SRZN | Common Stock | I | −1 885 000 | 0 | ||||||
| 2022-12-15 | 2022-12-14 | 4 | BLUTT MITCHELL J MD By Managed Account | SRZN | Common Stock | I | −450 827 | 0 | ||||||
| 2022-12-15 | 2022-12-14 | 4 | BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP | SRZN | Common Stock | I | −1 297 922 | 0 | ||||||
| 2022-12-15 | 2022-12-14 | 4 | BLUTT MITCHELL J MD By Consonance Capital Master Account LP | SRZN | Common Stock | I | −1 748 750 | 0 | ||||||
| 2022-03-03 | 2022-03-01 | 4 | Yeh Wen-Chen | SRZN | Option (right to buy) | D | 3,11 | 125 000 | 125 000 | |||||
| 2022-03-03 | 2022-03-01 | 4 | Parker Craig C | SRZN | Stock Option (right to buy) | D | 3,11 | 370 000 | 370 000 | |||||
| 2022-03-03 | 2022-03-01 | 4 | Williams Charles O | SRZN | Option (right to buy) | D | 3,11 | 125 000 | 125 000 | |||||
| 2022-03-03 | 2022-03-01 | 4 | Vanhove Geertrui | SRZN | Option Grant (right to buy) | D | 3,11 | 3,1100 | 125 000 | 389 | 125 000 | |||
| 2021-08-16 | 3 | COLUMN GROUP III, LP By The Column Group III, LP | SRZN | Common Stock | I | 4 343 245 | ||||||||
| 2021-08-16 | 3 | COLUMN GROUP III, LP By The Column Group III-A, LP | SRZN | Common Stock | I | 4 904 884 | ||||||||
| 2021-08-16 | 3 | Kutzkey Tim By The Column Group III, LP | SRZN | Common Stock | I | 4 343 245 | ||||||||
| 2021-08-16 | 3 | Kutzkey Tim By The Column Group III-A, LP | SRZN | Common Stock | I | 4 904 884 | ||||||||
| 2021-08-16 | 2021-08-12 | 4 | Parker Craig C | SRZN | Stock Option (right to buy) | D | 10,25 | 183 335 | 183 335 | |||||
| 2021-08-16 | 2021-08-12 | 4 | Vanhove Geertrui | SRZN | Employee Stock Option (right to buy) | D | 10,25 | 36 647 | 36 647 | |||||
| 2021-08-16 | 3 | Vanhove Geertrui | SRZN | Common Stock | D | 22 834 | ||||||||
| 2021-08-16 | 2021-08-12 | 4 | Williams Charles O | SRZN | Employee Stock Option (right to buy) | D | 10,25 | 14 597 | 14 597 | |||||
| 2021-08-16 | 3 | WOODHOUSE DAVID J | SRZN | Common Stock | D | 35 129 | ||||||||
| 2021-08-16 | 3 | Rothenberg Mace | SRZN | Common Stock | D | 35 129 | ||||||||
| 2021-08-16 | 3 | Haak-Frendscho Mary | SRZN | Common Stock | D | 35 129 | ||||||||
| 2021-08-16 | 3 | Berkenblit Anna | SRZN | Common Stock | D | 35 129 | ||||||||
| 2021-08-16 | 3 | Lin Shao-Lee | SRZN | Common Stock | D | 35 129 | ||||||||
| 2021-08-16 | 3 | Yeh Wen-Chen | SRZN | Common Stock | D | 219 560 | ||||||||
| 2021-08-16 | 3 | CHAI CHRISTOPHER Y | SRZN | Common Stock | D | 35 129 | ||||||||
| 2021-08-13 | 2021-08-11 | 4 | Consonance Life Sciences | SRZN | Warrants | I | 11,50 | −144 667 | 144 667 | |||||
| 2021-08-13 | 2021-08-11 | 4 | Consonance Life Sciences | SRZN | Warrants | I | 11,50 | −144 667 | 0 | |||||
| 2021-08-13 | 2021-08-11 | 4 | Consonance Life Sciences | SRZN | Common Stock | I | 1 451 000 | 1 885 000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Consonance Life Sciences | SRZN | Common Stock | I | 434 000 | 434 000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Consonance Life Sciences | SRZN | Class B Ordinary Shares | I | −1 451 000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Consonance Life Sciences | SRZN | Class B Ordinary Shares | I | −759 000 | 1 451 000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Consonance Life Sciences | SRZN | Class A Ordinary Shares | I | −434 000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Jarrett Jennifer | SRZN | Class B Ordinary Shares | D | −30 000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Jarrett Jennifer | SRZN | Common Stock | D | 30 000 | 30 000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Santel Donald J | SRZN | Class B Ordinary Shares | D | −30 000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Santel Donald J | SRZN | Common Stock | D | 30 000 | 30 000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Soffer Benny | SRZN | Warrants | I | 11,50 | −144 667 | 144 667 | |||||
| 2021-08-13 | 2021-08-11 | 4 | Soffer Benny | SRZN | Warrants | I | 11,50 | −144 667 | 0 | |||||
| 2021-08-13 | 2021-08-11 | 4 | Soffer Benny | SRZN | Common Stock | I | 1 451 000 | 1 885 000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Soffer Benny | SRZN | Common Stock | I | 434 000 | 434 000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Soffer Benny | SRZN | Class B Ordinary Shares | I | −1 451 000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Soffer Benny | SRZN | Class B Ordinary Shares | I | −759 000 | 1 451 000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Soffer Benny | SRZN | Class A Ordinary Shares | I | −434 000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Haqq Christopher | SRZN | Class B Ordinary Shares | D | −30 000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Haqq Christopher | SRZN | Common Stock | D | 30 000 | 30 000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Livingston Kevin Harold | SRZN | Warrants | I | 11,50 | −144 667 | 144 667 | |||||
| 2021-08-13 | 2021-08-11 | 4 | Livingston Kevin Harold | SRZN | Warrants | I | 11,50 | −144 667 | 0 | |||||
| 2021-08-13 | 2021-08-11 | 4 | Livingston Kevin Harold | SRZN | Common Stock | I | 1 451 000 | 1 885 000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Livingston Kevin Harold | SRZN | Common Stock | I | 434 000 | 434 000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Livingston Kevin Harold | SRZN | Class B Ordinary Shares | I | −1 451 000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Livingston Kevin Harold | SRZN | Class B Ordinary Shares | I | −759 000 | 1 451 000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | Livingston Kevin Harold | SRZN | Class A Ordinary Shares | I | −434 000 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Managed Account | SRZN | Warrants (right to buy) | I | 11,50 | 107 309 | 150 275 | |||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP | SRZN | Warrants (right to buy) | I | 11,50 | 308 940 | 432 640 | |||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Master Account LP | SRZN | Warrants (right to buy) | I | 11,50 | 416 250 | 582 917 | |||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Managed Account | SRZN | Warrants (right to buy) | I | 11,50 | 42 966 | 42 966 | |||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP | SRZN | Warrants (right to buy) | I | 11,50 | 123 700 | 123 700 | |||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Master Account LP | SRZN | Warrants (right to buy) | I | 11,50 | 166 667 | 166 667 | |||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Managed Account | SRZN | Common Stock | I | 321 928 | 450 828 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP | SRZN | Common Stock | I | 926 822 | 1 297 922 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Master Account LP | SRZN | Common Stock | I | 1 248 750 | 1 748 750 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Managed Account | SRZN | Common Stock | I | 128 900 | 128 900 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Managed Account | SRZN | Class A Ordinary Shares | I | −128 900 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP | SRZN | Common Stock | I | 371 100 | 371 100 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP | SRZN | Class A Ordinary Shares | I | −371 100 | 0 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Master Account LP | SRZN | Common Stock | I | 500 000 | 500 000 | ||||||
| 2021-08-13 | 2021-08-11 | 4 | BLUTT MITCHELL J MD By Consonance Capital Master Account LP | SRZN | Class A Ordinary Shares | I | −500 000 | 0 | ||||||
| 2021-05-19 | 2020-11-23 | 4/A | Consonance Life Sciences | CHFW | Warrant | D | 11,50 | 136 667 | 136 667 | |||||
| 2021-05-19 | 2020-11-23 | 4/A | Consonance Life Sciences | CHFW | Class A Ordinary Shares | D | 410 000 | 410 000 | ||||||
| 2021-05-19 | 2020-11-18 | 4/A | Consonance Life Sciences | CHFW | Class B Ordinary Shares | D | 0,0109 | −30 000 | −0 | 2 210 000 | ||||
| 2021-05-19 | 2020-11-18 | 4/A | Consonance Life Sciences | CHFW | Class B Ordinary Shares | D | 0,0109 | −30 000 | −0 | 2 210 000 | ||||
| 2021-05-19 | 2020-11-18 | 4/A | Consonance Life Sciences | CHFW | Class B Ordinary Shares | D | 0,0109 | −30 000 | −0 | 2 240 000 | ||||
| 2021-05-19 | 2020-11-10 | 4/A | Consonance Life Sciences | CHFW | Class B Ordinary Shares | D | −575 000 | 2 300 000 | ||||||
| 2021-05-19 | 2020-10-08 | 4/A | Consonance Life Sciences | CHFW | Class B Ordinary Shares | D | −718 750 | 2 875 000 | ||||||
| 2021-05-19 | 2020-09-04 | 4/A | Consonance Life Sciences | CHFW | Class B Ordinary Shares | D | 0,0070 | 3 593 750 | 25 | 3 593 750 | ||||
| 2021-05-19 | 2020-12-01 | 4/A | Soffer Benny | CHFW | Warrant | I | 11,50 | 8 000 | 144 667 | |||||
| 2021-05-19 | 2020-12-01 | 4/A | Soffer Benny | CHFW | Class A Ordinary Shares | I | 24 000 | 434 000 | ||||||
| 2021-05-19 | 2020-11-23 | 4/A | BLUTT MITCHELL J MD | CHFW | Warrant | I | 11,50 | 136 667 | 136 667 | |||||
| 2021-05-19 | 2020-11-23 | 4/A | BLUTT MITCHELL J MD | CHFW | Class A Ordinary Shares | I | 410 000 | 410 000 | ||||||
| 2021-05-19 | 2020-11-18 | 4/A | BLUTT MITCHELL J MD | CHFW | Class B Ordinary Shares | I | 0,0109 | −30 000 | −0 | 2 210 000 | ||||
| 2021-05-19 | 2020-11-18 | 4/A | BLUTT MITCHELL J MD | CHFW | Class B Ordinary Shares | I | 0,0109 | −30 000 | −0 | 2 210 000 | ||||
| 2021-05-19 | 2020-11-18 | 4/A | BLUTT MITCHELL J MD | CHFW | Class B Ordinary Shares | I | 0,0109 | −30 000 | −0 | 2 240 000 | ||||
| 2021-05-19 | 2020-11-10 | 4/A | BLUTT MITCHELL J MD | CHFW | Class B Ordinary Shares | I | −575 000 | 2 300 000 | ||||||
| 2021-05-19 | 2020-10-08 | 4/A | BLUTT MITCHELL J MD | CHFW | Class B Ordinary Shares | I | −718 750 | 2 875 000 | ||||||
| 2021-05-19 | 2020-09-04 | 4/A | BLUTT MITCHELL J MD | CHFW | Class B Ordinary Shares | I | 0,0070 | 3 593 750 | 25 | 3 593 750 | ||||
| 2021-05-19 | 2020-11-23 | 4/A | Soffer Benny | CHFW | Warrant | I | 11,50 | 136 667 | 136 667 | |||||
| 2021-05-19 | 2020-11-23 | 4/A | Soffer Benny | CHFW | Class A Ordinary Shares | I | 410 000 | 410 000 | ||||||
| 2021-05-19 | 2020-11-18 | 4/A | Soffer Benny | CHFW | Class B Ordinary Shares | I | 0,0109 | −30 000 | −0 | 2 210 000 | ||||
| 2021-05-19 | 2020-11-18 | 4/A | Soffer Benny | CHFW | Class B Ordinary Shares | I | 0,0109 | −30 000 | −0 | 2 210 000 | ||||
| 2021-05-19 | 2020-11-18 | 4/A | Soffer Benny | CHFW | Class B Ordinary Shares | I | 0,0109 | −30 000 | −0 | 2 240 000 | ||||
| 2021-05-19 | 2020-11-10 | 4/A | Soffer Benny | CHFW | Class B Ordinary Shares | I | −575 000 | 2 300 000 | ||||||
| 2021-05-19 | 2020-10-08 | 4/A | Soffer Benny | CHFW | Class B Ordinary Shares | I | −718 750 | 2 875 000 | ||||||
| 2021-05-19 | 2020-09-04 | 4/A | Soffer Benny | CHFW | Class B Ordinary Shares | I | 0,0070 | 3 593 750 | 25 | 3 593 750 | ||||
| 2021-05-19 | 2020-12-01 | 4/A | Consonance Life Sciences | CHFW | Warrant | D | 11,50 | 8 000 | 144 667 | |||||
| 2021-05-19 | 2020-12-01 | 4/A | Consonance Life Sciences | CHFW | Class A Ordinary Shares | D | 24 000 | 434 000 | ||||||
| 2021-05-19 | 2020-12-01 | 4/A | Livingston Kevin Harold | CHFW | Warrant | I | 11,50 | 8 000 | 144 667 | |||||
| 2021-05-19 | 2020-12-01 | 4/A | Livingston Kevin Harold | CHFW | Class A Ordinary Shares | I | 24 000 | 434 000 | ||||||
| 2021-05-19 | 2020-11-23 | 4/A | Livingston Kevin Harold | CHFW | Warrant | I | 11,50 | 136 667 | 136 667 | |||||
| 2021-05-19 | 2020-11-23 | 4/A | Livingston Kevin Harold | CHFW | Class A Ordinary Shares | I | 410 000 | 410 000 | ||||||
| 2021-05-19 | 2020-11-18 | 4/A | Livingston Kevin Harold | CHFW | Class B Ordinary Shares | I | 0,0109 | −30 000 | −0 | 2 210 000 | ||||
| 2021-05-19 | 2020-11-18 | 4/A | Livingston Kevin Harold | CHFW | Class B Ordinary Shares | I | 0,0109 | −30 000 | −0 | 2 210 000 | ||||
| 2021-05-19 | 2020-11-18 | 4/A | Livingston Kevin Harold | CHFW | Class B Ordinary Shares | I | 0,0109 | −30 000 | −0 | 2 240 000 | ||||
| 2021-05-19 | 2020-11-10 | 4/A | Livingston Kevin Harold | CHFW | Class B Ordinary Shares | I | −575 000 | 2 300 000 | ||||||
| 2021-05-19 | 2020-10-08 | 4/A | Livingston Kevin Harold | CHFW | Class B Ordinary Shares | I | −718 750 | 2 875 000 | ||||||
| 2021-05-19 | 2020-09-04 | 4/A | Livingston Kevin Harold | CHFW | Class B Ordinary Shares | I | 0,0070 | 3 593 750 | 25 | 3 593 750 | ||||
| 2021-05-19 | 2020-12-01 | 4/A | BLUTT MITCHELL J MD | CHFW | Warrant | I | 11,50 | 8 000 | 144 667 | |||||
| 2021-05-19 | 2020-12-01 | 4/A | BLUTT MITCHELL J MD | CHFW | Class A Ordinary Shares | I | 24 000 | 434 000 | ||||||
| 2021-05-19 | 3/A | BLUTT MITCHELL J MD Consonance Life Sciences, LLC | CHFW | Class B Ordinary Shares | I | 2 210 000 | ||||||||
| 2021-05-19 | 3/A | Soffer Benny Consonance Life Sciences, LLC | CHFW | Class B Ordinary Shares | I | 2 210 000 | ||||||||
| 2021-05-19 | 3/A | Livingston Kevin Harold Consonance Life Sciences, LLC | CHFW | Class B Ordinary Shares | I | 2 210 000 | ||||||||
| 2021-05-19 | 3/A | Consonance Life Sciences | CHFW | Class B Ordinary Shares | D | 2 210 000 | ||||||||
| 2020-12-04 | 2020-11-23 | 4 | BLUTT MITCHELL J MD By Managed Account | CHFW | Class A Ordinary Shares | I | 128 900 | 128 900 | ||||||
| 2020-12-04 | 2020-11-23 | 4 | BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP | CHFW | Class A Ordinary Shares | I | 371 100 | 371 100 | ||||||
| 2020-12-04 | 2020-11-23 | 4 | BLUTT MITCHELL J MD By Consonance Capital Master Account, LP | CHFW | Class A Ordinary Shares | I | 500 000 | 500 000 | ||||||
| 2020-12-03 | 2020-12-01 | 4 | Livingston Kevin Harold | CHFW | Warrant | I | 11,50 | 8 000 | 144 667 | |||||
| 2020-12-03 | 2020-12-01 | 4 | Livingston Kevin Harold | CHFW | Class A Ordinary Shares | I | 24 000 | 434 000 | ||||||
| 2020-12-03 | 2020-12-01 | 4 | Consonance Life Sciences | CHFW | Warrant | D | 11,50 | 8 000 | 144 667 | |||||
| 2020-12-03 | 2020-12-01 | 4 | Consonance Life Sciences | CHFW | Class A Ordinary Shares | D | 24 000 | 434 000 | ||||||
| 2020-12-03 | 2020-12-01 | 4 | Soffer Benny | CHFW | Warrant | I | 11,50 | 8 000 | 144 667 | |||||
| 2020-12-03 | 2020-12-01 | 4 | Soffer Benny | CHFW | Class A Ordinary Shares | I | 24 000 | 434 000 | ||||||
| 2020-12-03 | 2020-12-01 | 4 | BLUTT MITCHELL J MD | CHFW | Warrant | I | 11,50 | 8 000 | 144 667 | |||||
| 2020-12-03 | 2020-12-01 | 4 | BLUTT MITCHELL J MD | CHFW | Class A Ordinary Shares | I | 24 000 | 434 000 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Consonance Life Sciences | CHFW | Warrant | D | 11,50 | 136 667 | 136 667 | |||||
| 2020-11-25 | 2020-11-23 | 4 | Consonance Life Sciences | CHFW | Class A Ordinary Shares | D | 410 000 | 410 000 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Soffer Benny | CHFW | Warrant | I | 11,50 | 136 667 | 136 667 | |||||
| 2020-11-25 | 2020-11-23 | 4 | Soffer Benny | CHFW | Class A Ordinary Shares | I | 410 000 | 410 000 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | BLUTT MITCHELL J MD | CHFW | Warrant | I | 11,50 | 136 667 | 136 667 | |||||
| 2020-11-25 | 2020-11-23 | 4 | BLUTT MITCHELL J MD | CHFW | Class A Ordinary Shares | I | 410 000 | 410 000 | ||||||
| 2020-11-25 | 2020-11-23 | 4 | Livingston Kevin Harold | CHFW | Warrant | I | 11,50 | 136 667 | 136 667 | |||||
| 2020-11-25 | 2020-11-23 | 4 | Livingston Kevin Harold | CHFW | Class A Ordinary Shares | I | 410 000 | 410 000 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
